TREA

99000412 - CARIS LIFE SCIENCES

Follow

Information

  • Trademark
  • 99000412
  • Serial Number
    99000412
  • Filing Date
    January 16, 2025
    16 days ago
  • Transaction Date
    January 16, 2025
    16 days ago
  • Status Date
    January 16, 2025
    16 days ago
  • Status Code
    630
  • Attorney Docket Number
    C114025 3031
    Attorney Name
    Anne Fleeson
  • Owners
Information
Mark Drawing Code
0
Mark Identification
CARIS LIFE SCIENCES
Case File Statements
  • DM0000: The mark consists of the shape of a shield with three arched, half-concentric, curved lines within the shield shape. The words CARIS LIFE SCIENCES are located to the right side of the shield with the "A" in the word CARIS being stylized. The word "CARIS" is over the wording "LIFE SCIENCES".
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services
  • GS0421: Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes
Case File Event Statements
  • 1/16/2025 - 16 days ago
    1 - NEW APPLICATION ENTERED Type: NWAP